Drug 'may slow' Alzheimer's brain death
Developing such a treatment is one of the biggest challenges in medicine. But serious scientific questions remain as the drug - LMTX - inexplicably works only in patients not taking other dementia pills.
The data on 891 patients was presented at the Alzheimer's Association International Conference in Toronto. Overall, the trial - which treated patients for 15 months - was a flop, as there appeared to be no benefit to taking LMTX.
However, an analysis on just the 15% of the patients who had not already been taking drugs to help manage their symptoms showed a benefit. In this tiny subset of patients, tests showed thinking power was maintained and MRI scans found the death of brain cells was reduced.
Dr Serge Gauthier, the director of the Alzheimer's Disease Research Unit at McGill University in Canada, said: "It is both encouraging to see improvements of this magnitude in the standard cognitive and functional tests and reassuring to see the supporting brain scan evidence of a slowing in disease progression.
"In a field that has been plagued by consistent failures of novel drug candidates in late-stage clinical trials and where there has been no practical therapeutic advance for over a decade, I am excited."
Even the company that manufactures LMTX, TauRX, cannot explain why it might work only in patients not taking other dementia drugs.
Dr David Reynolds, the chief scientific officer at the Alzheimer's Research UK charity, told the BBC News website: "It does worry me as a scientist why it doesn't work with other therapies."
Possible explanations include:
- the drugs interfere with each other
- there is something different about the patients not on other medication
- the small size of the sub-group in the trial means the results may have been fluked
Dr Reynolds added: "The data suggests it is slowing down the disease, but the important caveat is these small numbers.
"It is encouraging, but we need more data and will have to run a study with it as just a monotherapy [on its own]. It will still be years from reaching patients even assuming it works."
- Jun 2021 (1)
- Feb 2020 (1)
- Apr 2018 (1)
- Mar 2018 (1)
- Jan 2018 (3)
- Dec 2017 (5)
- Nov 2017 (7)
- Oct 2017 (8)
- Sep 2017 (8)
- Aug 2017 (4)
- Jul 2017 (5)
- Jun 2017 (5)
- May 2017 (3)
- Apr 2017 (3)
- Mar 2017 (4)
- Feb 2017 (2)
- Jan 2017 (1)
- Dec 2016 (5)
- Nov 2016 (8)
- Oct 2016 (7)
- Sep 2016 (2)
- Aug 2016 (6)
- Jul 2016 (6)
- Jun 2016 (1)
- A Career in Care - Jessica's Story
- Routes Blog 2020!
- Liverpool CQC inspection achieves a Good
- A huge THANK YOU to all our fantastic field and branch staff!
- Recruitment Opportunity in Newcastle
- Preston has moved
- Tameside's Christmas Toy Collection
- Certificate of Inspiration
- Tameside receive an OUTSTANDING in Care
Most Popular Posts
- Healthcare Assistants wanted in Blackpool to care for a gentleman and lady with spinal injuries
- Mental Health campaign receives additional funding
- Routes Healthcare need experienced childminders across the North West of England
- Accounts & Payroll Trainee Vacancy Routes Healthcare - Macclesfield
- Social Worker Struck Off
- Routes Healthcare Blackpool is committed to the modern apprenticeship scheme
- Routes Childcare - The local company with the Worldwide experience!
- Cancer 'Smart Bomb' Successfully Tested in US
- Personalisation 'at high risk of failure', Norman Lamb told
There are currently no comments for this post, use the form below to be the first!.